Deep Breath Intelligence
Deep Breath Intelligence AG is a Swiss MedTech company specializing in breath analysis for precision medicine. Founded in 2018, it develops non-invasive, real-time solutions for disease detection and therapeutic drug monitoring, leveraging advanced data science, machine learning, and high-resolution mass spectrometry technologies. The company's mission is to improve health outcomes through innovative breath analysis applications across various medical fields.
Industries
Nr. of Employees
small (1-50)
Deep Breath Intelligence
Products
Breath-based therapeutic drug monitoring test (for epilepsy)
A non-invasive breath test that estimates blood concentration of antiseizure medication and predicts risk of side effects and seizures from a single exhale; intended to support treatment decisions.
Hardware and software platform for breath analysis
Integrated hardware and software portfolio that enables collection, measurement (SESI-HRMS) and analysis of breath samples to generate clinical insights.
Breath-based therapeutic drug monitoring test (for epilepsy)
A non-invasive breath test that estimates blood concentration of antiseizure medication and predicts risk of side effects and seizures from a single exhale; intended to support treatment decisions.
Hardware and software platform for breath analysis
Integrated hardware and software portfolio that enables collection, measurement (SESI-HRMS) and analysis of breath samples to generate clinical insights.
Services
Design and execution of clinical studies including protocol development, ethics, integrated CRF, data collection and coordination with clinical partners.
Standardized sample collection, analytical measurement (SESI-HRMS), data analysis and clinical interpretation for respiratory, metabolic, oncology and other applications.
Full-cycle support in data processing, governance, sharing, analysis and visualization of breath and related omics data using ML methods.
Operation and integration of third-party mass spectrometry/measurement instruments with established SOPs for breath analysis workflows.
Assistance with participant engagement and coordination for voluntary breath analysis studies in collaboration with university hospitals.
Design and execution of clinical studies including protocol development, ethics, integrated CRF, data collection and coordination with clinical partners.
Standardized sample collection, analytical measurement (SESI-HRMS), data analysis and clinical interpretation for respiratory, metabolic, oncology and other applications.
Full-cycle support in data processing, governance, sharing, analysis and visualization of breath and related omics data using ML methods.
Operation and integration of third-party mass spectrometry/measurement instruments with established SOPs for breath analysis workflows.
Assistance with participant engagement and coordination for voluntary breath analysis studies in collaboration with university hospitals.
Expertise Areas
- Breath metabolomics
- Therapeutic drug monitoring
- Clinical study management
- Machine learning for diagnostics
Key Technologies
- Secondary electrospray ionization (SESI)
- High-resolution mass spectrometry (HRMS, Orbitrap)
- Real-time VOC analysis
- Machine learning and neural networks
News & Updates
Recognition for innovative breath analysis technology.
Acknowledgment of the company's potential in healthtech.
Supporting education and research collaborations.
An article discussing the importance of TDM in personalized healthcare and how DBI's breath analysis technology supports it.
Zünder accelerator award 2023
Award recognizing innovation in breath analysis technology.
Recognition for innovative breath analysis technology.
Acknowledgment of the company's potential in healthtech.
Supporting education and research collaborations.
An article discussing the importance of TDM in personalized healthcare and how DBI's breath analysis technology supports it.
Zünder accelerator award 2023
Award recognizing innovation in breath analysis technology.